文献速递心脑血管急症重症综合管理与镇静镇痛

抗血小板药物与止血生物标志物或可解释脑出血血肿形态与后续扩大的关联

Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage.
PubMed 文献 · Neurocrit Care · 2021-10-27
一句话结论急性脑出血患者CT上的黑洞征和岛征与血小板活性降低及入院前氯吡格雷使用相关,提示血肿形态可能反映抗血小板药物导致的止血功能减退。

该研究纳入2006至2019年连续330例急性脑出血患者,前瞻性记录入院时血小板活性(血小板阿司匹林检测)和用药史(阿司匹林、氯吡格雷),由盲法判读者记录诊断CT上的血肿形态。结果显示黑洞征最常见(101例,30%),其次为岛征(57例,17%)和混合征(32例,10%)。有黑洞征或岛征的患者血小板活性显著降低,入院前氯吡格雷使用与黑洞征相关(OR 2.25,95%CI 1.02-4.98,P=0.04)。结论提示CT血肿形态并非偶然,可能与抗血小板药物导致的止血功能减退有关。

要点

  • 急性脑出血患者中黑洞征最常见(101/330,30%),其次为岛征(57/330,17%)和混合征(32/330,10%)。
  • 有黑洞征者血小板活性更低(511 [430-610] vs. 562 [472-628] aspirin reaction units,P=0.01)。
  • 有岛征者血小板活性更低(505 [434-574] vs. 559 [462-629] aspirin reaction units,P=0.004)。
  • 入院前氯吡格雷使用与黑洞征独立相关(OR 2.25,95%CI 1.02-4.98,P=0.04)。
  • CT血肿形态可能反映抗血小板药物导致的止血功能减退,而非偶然现象。

适用人群与场景

  • 2006至2019年连续纳入的330例急性脑出血患者。

诊断标准与关键阈值

  • 血肿形态由盲法判读者从诊断CT上记录,包括黑洞征、岛征和混合征。
  • 血小板活性采用血小板阿司匹林检测,以aspirin reaction units表示。
  • 入院时前瞻性记录用药史(阿司匹林、氯吡格雷)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为连续病例队列,样本量330例,单中心(原文未明确提及中心数),人群为急性脑出血患者。
  • 黑洞征101例(30%),岛征57例(17%),混合征32例(10%)。
  • 黑洞征者血小板活性511 [430-610] vs. 562 [472-628] aspirin reaction units,P=0.01。
  • 岛征者血小板活性505 [434-574] vs. 559 [462-629] aspirin reaction units,P=0.004。
  • 入院前氯吡格雷使用与黑洞征相关:OR 2.25,95%CI 1.02-4.98,P=0.04。

证据类型、等级与局限

  • 证据类型为单中心连续病例队列研究。
  • 局限:单中心、观察性设计,样本量330例,原文未提及多中心验证。

对床旁实践的改变

  • 对于急性脑出血患者,CT上出现黑洞征或岛征时,应关注入院前抗血小板药物(尤其是氯吡格雷)使用史及血小板功能状态。
  • 原文未提及基于血肿形态改变治疗决策的具体推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: To test the hypothesis that appearances of intracranial hematomas on diagnostic computed tomography (CT) are not idiosyncratic and reflect a biologically plausible mechanism, we evaluated the association between hematoma appearance on CT, biomarkers of platelet activity, and antiplatelet or anticoagulant medication use prior to admission.

METHODS: We studied 330 consecutively identified patients from 2006 to 2019. Biomarkers of platelet activity (platelet aspirin assay) and medication history (aspirin, clopidogrel) were prospectively recorded on admission. A blinded interpreter recorded the presence of hematoma appearances from the diagnostic scan. Associations were tested with parametric or nonparametric statistics, as appropriate.

RESULTS: The black hole sign (101, 30%) was most prevalent, followed by the island sign (57, 17%) and blend sign (32, 10%). There was reduced platelet activity in patients with a black hole sign (511 [430-610] vs. 562 [472-628] aspirin reaction units, P = 0.01) or island sign (505 [434-574] vs. 559 [462-629] aspirin reaction units, P = 0.004). Clopidogrel use prior to admission was associated with the black hole sign (odds ratio 2.25, 95% confidence interval 1.02-4.98, P = 0.04).

CONCLUSIONS: In patients with acute intracerebral hemorrhage, hematoma appearances on CT are associated with biomarkers of platelet activity and clopidogrel use prior to admission. Appearances of intracranial hematomas on CT may reflect reduced hemostasis from antiplatelet medication use.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Tang M, Shin HJ, Metcalf-Doetsch W, et al. Antiplatelet Medications and Biomarkers of Hemostasis May Explain the Association of Hematoma Appearance and Subsequent Hematoma Expansion After Intracerebral Hemorrhage. Neurocrit Care. 2021. PMID: 34708342. doi:10.1007/s12028-021-01369-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。